PRRT2 and neoplasm: PEP005 (ingenol-3-angelate), an activator of protein kinase C (PKC), induces nuclear translocation of PKCδ, exhibiting activity of clinical anti-tumor and actinic keratosis28, 29, 30, 31, and potential for HIV latency reactivation32, 33, 34.